Is Feel Free Drink Safe? Kratom, Kava, and Addiction Risks

No, the Feel Free drink is not a safe wellness supplement. 

Feel Free drink is a kratom and kava concentrate sold in 2-ounce blue bottles at gas stations, smoke shops, and convenience stores across the United States.

Feel Free Classic, produced by Botanic Tonics, contains mitragynine, the primary psychoactive alkaloid in kratom. Mitragynine binds to mu-opioid receptors in the brain. Regular use produces tolerance, physical dependence, and withdrawal symptoms that closely mirror prescription opioid discontinuation.

Many people who start Feel Free for relaxation or productivity find they cannot stop without significant discomfort. Understanding what this drink actually contains, and what it does to the brain, is the first step toward recognizing when use has crossed into dependence.

Key Takeaways

• According to a 2025 CDC Morbidity and Mortality Weekly Report, kava-related calls to U.S. poison control centers increased 383% from 2011 to 2025. Approximately one-third of 2025 calls also involved kratom, and eight kava-related deaths were reported during the study period.
• In 2023, Botanic Tonics settled the Torres v. Botanic Tonics class action lawsuit for $8.75 million. The lawsuit alleged misleading marketing that obscured kratom’s opioid-like properties from consumers who purchased Feel Free between March 2019 and March 2025.
• Kratom’s primary active alkaloids, mitragynine and 7-hydroxymitragynine (7-OH), bind to mu-opioid receptors; 7-OH is approximately 13 times more potent than morphine at these receptors, driving the physical dependence documented in regular Feel Free users.
• The FDA classified kratom as an opioid in 2018. Feel Free remains unregulated, and kratom has been banned in Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin.
• Users reporting Feel Free dependence describe consuming 5 to 10 bottles daily at costs exceeding $3,000 per month. This pattern satisfies multiple DSM-5 criteria for a substance use disorder.

What Is Feel Free Drink and What Does It Contain?

Feel Free drink is a 2-ounce concentrated tonic produced by Botanic Tonics, containing kratom leaf extract and kava root extract as its primary psychoactive ingredients in a formulation marketed as a plant-based wellness product.

Kratom: The Primary Ingredient in Feel Free

Kratom derives from Mitragyna speciosa, a tropical tree native to Southeast Asia whose leaves contain more than 25 alkaloids. Mitragynine comprises approximately 66% of total alkaloid content by weight. Among psychoactive plant-derived substances that produce opioid-like dependence without federal controlled substance classification, kratom occupies a uniquely high-risk position due to its receptor binding profile.

At low doses, mitragynine produces stimulant effects including increased energy and reduced fatigue. At higher doses, it acts as a full mu-opioid receptor agonist, generating sedation, analgesia, and euphoria that mirrrors opioid drug effects. This dual dose-dependent mechanism explains why Feel Free users begin with recreational use and escalate into compulsive daily consumption.

Kava: The Secondary Ingredient and Liver Toxicity Risk

Kava derives from the root of Piper methysticum, a plant native to Pacific Island cultures where it has been consumed ceremonially for centuries. Its active constituents, kavalactones, potentiate GABA-A receptor activity and inhibit voltage-gated sodium channels, producing dose-dependent anxiolysis and central nervous system depression.

Kava is not classified as physically addictive at traditional ceremonial doses. Commercial kava concentrates, including those in Feel Free, deliver kavalactone doses substantially higher than traditional preparations. Sustained daily use of concentrated kava formulations produces hepatotoxicity, with documented liver damage cases appearing in the medical literature and in FDA adverse event reports.

How Feel Free Is Marketed Versus What the Label Contains

Botanic Tonics originally marketed Feel Free primarily around kava, describing the product as made from ancient plants from the South Pacific and Southeast Asia. Marketing materials frequently omitted kratom or buried it in ingredient lists without specifying quantities. The product label did not disclose individual ingredient amounts until 2022.

The Torres v. Botanic Tonics lawsuit alleged that kratom, not kava, was Feel Free’s dominant active ingredient. Plaintiffs also claimed Botanic Tonics had targeted individuals with prior addiction histories in social media advertising. By 2023, Feel Free had generated an estimated $32 million in annual revenue and secured partnerships with athletic programs at three major universities.

How Kratom and Kava in Feel Free Affect the Brain

Kratom and kava in Feel Free drive neurochemical changes across the mu-opioid receptor system and GABA-A receptor complex, producing physical dependence through two distinct but additive pharmacological pathways that become progressively harder to reverse with sustained daily use.

Mitragynine and Mu-Opioid Receptor Binding

Mitragynine, kratom’s primary alkaloid, binds to mu-opioid receptors in the brain’s reward circuitry, including the nucleus accumbens and locus coeruleus. This binding produces analgesia, euphoria, and sedation at doses achievable through routine Feel Free consumption. The brain compensates by downregulating mu-opioid receptor density and sensitivity, establishing tolerance.

Receptor downregulation means progressively higher Feel Free doses are required to achieve the same effect. When intake stops, the underregulated opioid system rebounds into a hyperexcitable state. This rebound generates the anxiety, muscle pain, and insomnia characteristic of Feel Free withdrawal, a pattern indistinguishable from prescription medication dependence discontinuation syndromes.

7-Hydroxymitragynine: The More Potent Kratom Alkaloid

7-Hydroxymitragynine (7-OH) is a minor kratom alkaloid present in smaller quantities than mitragynine but substantially more potent at mu-opioid receptors. Research estimates 7-OH is approximately 13 times more potent than morphine at mu-opioid receptors, making it a primary driver of both euphoria and physical dependence in kratom users.

In Feel Free’s concentrated extract formulation, 7-OH delivers opioid receptor stimulation at doses that exceed those achievable through traditional kratom leaf preparations. This potency differential explains why Feel Free users report faster dependence onset compared to loose-leaf kratom products. The 7-OH contribution also explains why Feel Free withdrawal resembles full opioid withdrawal rather than mild herbal discontinuation.

Kavalactones and GABA-A Receptor Activity

Kavalactones, the active compounds in kava, modulate GABA-A receptors through a binding mechanism distinct from benzodiazepines. This activity produces sedation and anxiolysis that compounds the mu-opioid receptor effects of kratom. Together, the two mechanisms generate the relaxed euphoria that Feel Free users report and that drives its appeal as an alcohol alternative.

Kavalactone GABA-A activity does not produce physical dependence equivalent to benzodiazepines at standard doses. However, regular kavalactone use generates psychological dependence and behavioral tolerance in daily consumers. The hepatic burden of kavalactone metabolism, combined with kratom alkaloid processing demands on the CYP3A4 enzyme system, significantly elevates liver injury risk in anyone consuming multiple Feel Free bottles daily.

Why the Combination of Kratom and Kava Is More Dangerous Than Either Alone

Kratom and kava each independently depress the central nervous system through separate receptor mechanisms. Combined in Feel Free’s concentrated formulation, mitragynine mu-opioid agonism and kavalactone GABA-A potentiation produce additive CNS depression that accelerates neuroadaptation and dependence onset. Pharmacists describe this combination as creating an overstimulating pharmacological profile that elevates addiction risk beyond either ingredient in isolation.

The combined CNS depression also substantially elevates overdose risk when Feel Free is used alongside alcohol, benzodiazepines, or other opioids. These polypharmacy combinations stack respiratory depressant mechanisms and account for the majority of serious adverse events in kava-kratom poison control data. According to the 2025 CDC MMWR, approximately 43% of kava-related poison control calls involved co-use with other CNS depressants, including ethanol.

Feel Free Withdrawal: Symptoms and Timeline

Feel Free withdrawal begins within hours of the last dose and follows a trajectory closely resembling opioid withdrawal, reflecting kratom’s mu-opioid receptor-mediated physical dependence with an additional GABA-modulated component from sustained kava exposure.

Feel Free Withdrawal Timeline

The following timeline reflects patterns reported by users and consistent with kratom and opioid discontinuation literature:

1. Stage 1 (6 to 12 hours after last dose): Initial onset Anxiety, restlessness, yawning, and rhinorrhea emerge as mu-opioid receptor hyperexcitability develops. Users describe an urgent craving for another bottle. Mild sweating and muscle tension appear.
2. Stage 2 (12 to 36 hours): Peak acute phase Muscle aches, nausea, vomiting, and diarrhea intensify as opioid receptor rebound reaches maximum severity. Insomnia develops despite physical exhaustion. Irritability and dysphoria peak during this window, closely mirroring presentations managed under Clinical Opiate Withdrawal Scale (COWS) protocol in clinical detox settings.
3. Stage 3 (36 to 72 hours): Sustained acute phase Physical symptoms begin gradual resolution but psychological symptoms, including depression, anhedonia, and intense cravings, remain severe. Users who attempt unsupervised withdrawal most commonly relapse during this stage. Headache, hot flashes, and tremors persist.
4. Stage 4 (3 to 7 days): Sub-acute phase Acute physical discomfort subsides. Persistent insomnia, low mood, cognitive fog, and cravings continue to impair daily function. High-volume users, those consuming 5 or more bottles daily for extended periods, report this phase extending significantly beyond 7 days.

Users consuming multiple bottles daily for months describe withdrawal lasting 2 to 4 weeks, meeting criteria for protracted withdrawal syndrome consistent with opioid and polysubstance discontinuation patterns documented in the clinical literature.

When to Seek Medical Help for Feel Free Withdrawal

Feel Free withdrawal is not reliably safe to manage without medical oversight, particularly after high-dose or prolonged daily use. Unsupervised withdrawal risks rapid dehydration from gastrointestinal losses, cardiac arrhythmias from electrolyte depletion, and severe psychological distress including suicidal ideation, which has been reported in case series involving heavy kratom users.

Individuals who have been consuming multiple bottles daily, or who have used Feel Free alongside other CNS depressants, should not attempt cessation without professional supervision. The severity and duration of Feel Free withdrawal are directly proportional to daily dose and duration of use, making clinical assessment essential before discontinuation.

Signs of Feel Free Drink Addiction and Health Risks

Feel Free addiction follows the behavioral and physiological pattern of a substance use disorder, with escalating consumption, failed cessation attempts, and continued use despite documented physical and psychological harm that satisfies multiple DSM-5 diagnostic criteria.

Common Signs of Feel Free Dependence

Common signs that Feel Free use has progressed to physical dependence include:

• Tolerance development: Requiring progressively more bottles per session to achieve the same effect, with users advancing from one to multiple bottles daily over weeks to months of regular consumption.
• Withdrawal-driven use: Consuming Feel Free specifically to prevent anxiety, irritability, or physical discomfort rather than for mood enhancement. This shift marks the clinical transition from misuse to physical dependence.
• Supply preoccupation: Planning daily activities around Feel Free availability, purchasing in bulk from multiple locations, or experiencing significant distress when the product is unavailable.
• Continued use despite harm: Persisting with Feel Free after experiencing liver symptoms, significant weight loss, cognitive impairment, financial strain, or relationship damage directly attributable to the drink.
• Failed cessation attempts: Repeatedly attempting to cut down or stop without success, particularly after experiencing withdrawal symptoms during prior attempts.

Severe Signs of Feel Free Dependence and Physical Complications

Severe signs of Feel Free addiction requiring prompt medical evaluation include:

• High-volume daily consumption: Consuming 5 to 10 or more bottles per day at costs reaching $3,000 monthly. This intake level delivers kratom alkaloid doses far above any studied clinical range and is associated with accelerated physical deterioration, including dermatological changes and organ dysfunction.
• Skin and dermatological changes: Persistent xerosis, hyperpigmentation, and skin texture changes consistent with kratom-induced dermopathy and kavalactone accumulation. Users describe skin becoming dry, scaly, and discolored with prolonged daily use.
• Hepatic symptoms: Jaundice, abdominal pain, abnormal liver function tests, and abdominal swelling indicating hepatotoxicity from combined kavalactone and kratom alkaloid hepatic burden. These symptoms require immediate medical evaluation.
• Neurological effects: Seizures, confusion, and loss of coordination in the context of combined kratom and kava toxicity. Poison control center data include adolescent cases presenting with seizures and altered mental status following Feel Free ingestion.

Seek emergency care immediately if Feel Free use produces seizures, jaundice, altered consciousness, difficulty breathing, or suicidal ideation.

Long-Term Risks of Daily Feel Free Use

Long-term daily Feel Free consumption produces progressive liver injury through two independent hepatotoxic pathways. Kavalactones generate reactive oxygen species that damage hepatocytes, while kratom alkaloids impose additional oxidative burden through extensive CYP3A4 hepatic metabolism. Combined daily exposure accelerates fibrotic changes that clinical monitoring may not detect until significant damage has already occurred.

Neurologically, sustained mu-opioid receptor agonism from mitragynine and 7-OH depletes dopaminergic reserves in the nucleus accumbens, producing persistent anhedonia and cognitive impairment that continue even after cessation. This dopaminergic depletion contributes to protracted withdrawal syndrome and significantly elevates relapse risk during the first 2 to 4 weeks of abstinence. Recovery from long-term Feel Free use requires both clinical support and structured behavioral intervention to allow neurochemical restoration.

Treatment for Feel Free Drink Dependence at The Grove Estate

The Grove Estate Addiction Treatment provides medically supervised residential care for adults with kratom and kava dependence, including those who have developed Feel Free use disorder, at its Indiana facility.

1- Medical Detox

Medical detox at The Grove Estate provides 24-hour physician-supervised withdrawal management for adults discontinuing Feel Free and other opioid-like substances. Clinical staff apply symptomatic medication protocols to manage anxiety, insomnia, gastrointestinal distress, and muscle pain throughout the acute withdrawal window. For individuals with suspected hepatic involvement, medical monitoring during detox reduces the risk of undetected liver complications during the most physically vulnerable phase of cessation.

2- Residential Addiction Treatment

Residential addiction treatment at The Grove Estate removes access to Feel Free and other substances while providing a structured therapeutic environment for the sub-acute and early recovery phases. Programming includes individual therapy, Cognitive Behavioral Therapy group sessions, Dialectical Behavior Therapy skills training, and relapse prevention work targeting the craving patterns and behavioral triggers associated with Feel Free dependence. Therapist continuity from detox through residential significantly improves outcomes for kratom-dependent individuals.

3- Dual Diagnosis Treatment

Many people who develop Feel Free dependence began using the drink to self-manage anxiety, depression, or the emotional consequences of prior substance use. Dual diagnosis treatment at The Grove Estate addresses both kratom and kava dependence and any co-occurring mental health conditions simultaneously, reducing the risk of substituting Feel Free with another psychoactive substance during recovery. Integrated dual-diagnosis care delivers substantially better long-term outcomes than addressing substance use and mental health in separate treatment episodes.

Frequently Asked Questions

What Is Feel Free Tonic Used For?

Feel Free drink is marketed by Botanic Tonics as a tonic for relaxation, focus, and mood enhancement, promoted as a non-alcoholic alternative to social drinking. Users report consuming it to relieve anxiety, manage stress, boost energy, or avoid alcohol. In clinical practice, it is better described as a kratom and kava concentrate. Regular use frequently transitions from intentional wellness consumption to dependence-driven intake. 

Is Kava an Opioid?

Kava is not an opioid. Kava’s active compounds, kavalactones, modulate GABA-A receptors and do not bind to mu-opioid receptors. However, Feel Free combines kava with kratom, which does act on mu-opioid receptors. The opioid-like dependence and withdrawal reported by Feel Free users comes primarily from kratom’s mitragynine and 7-hydroxymitragynine content, not from the kava component. 

Can You Get Addicted to Feel Free?

Yes. Feel Free contains kratom, which produces physical dependence through mu-opioid receptor agonism with sustained use. Users report escalating consumption, withdrawal symptoms when stopping, and repeated failed attempts to quit. These patterns satisfy DSM-5 criteria for a substance use disorder. Addiction professionals now treat Feel Free-specific kratom dependence as a distinct clinical presentation requiring structured medical and behavioral intervention. 

How Much Kratom Is in Feel Free Drink?

The exact mitragynine content per bottle has not been consistently disclosed or independently verified at a standard level. Botanic Tonics added quantity information to the label in 2022 following legal pressure from the Torres v. Botanic Tonics litigation. Without FDA-mandated dosing standards for kratom products, the actual alkaloid concentration in any individual Feel Free bottle cannot be reliably predicted by consumers. 

Is Feel Free FDA Approved?

No. Feel Free is not FDA approved. The FDA has not approved kratom for any medical use and classified it as an opioid in 2018. In May 2023, the FDA seized approximately 250,000 bottles of Feel Free, citing inadequate safety data for kratom as a dietary ingredient. The case was later dropped, but neither kratom nor kava in Feel Free has undergone FDA safety review for use as a food or drug ingredient. 

Do You Have to Be 21 to Buy Feel Free Tonic?

Age requirements for Feel Free vary by state and retailer. As part of the Torres v. Botanic Tonics settlement, Botanic Tonics agreed to limit sales to individuals 21 and older. However, Feel Free has historically been sold without consistent age verification at gas stations and convenience stores. Several states with Kratom Consumer Protection Acts independently set their own minimum purchase ages. 

What Are Feel Free Withdrawal Symptoms?

Feel Free withdrawal symptoms include anxiety, restlessness, muscle aches, nausea, vomiting, diarrhea, insomnia, hot flashes, and intense cravings. Symptoms emerge within 6 to 12 hours of the last dose and peak between 12 and 36 hours. Heavy users consuming multiple bottles daily report severe symptoms lasting 2 to 4 weeks, consistent with protracted withdrawal syndrome documented in opioid dependence literature. 

References

1. Centers for Disease Control and Prevention. (2025). Increase in poison center reports linked to kratom-containing kava products, United States, 2000-2025. Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/volumes/75/wr/mm7512a1.htm
2. Food and Drug Administration. (2018). Statement on kratom. U.S. Department of Health and Human Services. https://www.fda.gov/news-events/press-announcements/statement-fda-and-scientific-evidence-kratom
3. National Institute on Drug Abuse. (2022). Kratom drug facts. https://nida.nih.gov/publications/drugfacts/kratom
4. Grundmann, O. (2021). Patterns of kratom use and health impact in the US. Drug and Alcohol Dependence, 222, 108-629.
5. Holstege, C. P., et al. (2025). Resurgence of kava-related poison center exposures and co-use with kratom. Morbidity and Mortality Weekly Report, 75(12).
6. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
7. Rettner, R. (2025, August 26). Why Feel Free, a drink with kratom and kava, has many saying they’re becoming addicted. CNN Health.
8. Shoichet, C. E. (2025, August 7). Users report serious health effects from kratom-containing herbal supplement. Fox News Health.